Clinical correlates of subsyndromal depression in African American individuals with psychosis: The relationship with positive symptoms and comorbid substance dependence.


Journal

Schizophrenia research
ISSN: 1573-2509
Titre abrégé: Schizophr Res
Pays: Netherlands
ID NLM: 8804207

Informations de publication

Date de publication:
04 2019
Historique:
received: 19 02 2018
revised: 24 09 2018
accepted: 23 10 2018
pubmed: 30 11 2018
medline: 18 6 2020
entrez: 29 11 2018
Statut: ppublish

Résumé

Patients with psychosis exhibit subsyndromal depressive symptoms during the course of illness and yet the clinical correlates of these symptoms remain under-investigated. We aimed to investigate the clinical correlates of subsyndromal depression in psychosis including the extent to which they mediate commonly observed comorbid substance dependence. We developed a model of depression in a non-clinical sample recruited via Amazon's Mechanical Turk (N = 266), and confirmed that model in a locally recruited African-American clinical sample comprising psychotic and non-psychotic individuals (N = 256). Using scores from this model we tested: the strength of relationships between depressive symptomatology and positive, negative and disorganized symptoms in a range of psychotic disorders; whether depressive symptoms were higher in individuals with affective psychoses versus schizophrenia; and if depressive symptomatology mediated the relationship between psychosis and substance dependence. Subsyndromal depressive symptomatology was significantly higher in individuals with psychosis than without psychosis, but did not significantly differ between affective and non-affective psychotic groups. Depressive symptomatology was significantly related to positive (but not negative or disorganized) psychotic symptoms, and mediated the relationship between psychosis and substance dependence. The present study underlines the importance of assessing subsyndromal depression in patients with psychosis, and generates a number of testable predictions for future work. In particular, the examination of the relationships between comorbid psychopathology, namely depression and substance abuse, may improve insight into the neurobiology of psychosis.

Identifiants

pubmed: 30482645
pii: S0920-9964(18)30624-8
doi: 10.1016/j.schres.2018.10.022
pmc: PMC6486464
mid: NIHMS1511483
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

333-346

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH106324
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Références

J Clin Psychol. 2006 Jan;62(1):123-46
pubmed: 16287149
Schizophr Bull. 2017 Mar 1;43(2):240-244
pubmed: 27421793
Schizophr Bull. 2009 Mar;35(2):383-402
pubmed: 19011234
Curr Opin Psychiatry. 2008 Jan;21(1):14-8
pubmed: 18281835
Acta Psychiatr Scand. 2013 Nov;128(5):327-46
pubmed: 23379898
Br J Clin Psychol. 2003 Jun;42(Pt 2):111-31
pubmed: 12828802
J Affect Disord. 2012 Sep;140(1):38-47
pubmed: 22099566
Am J Psychiatry. 2017 Nov 1;174(11):1064-1074
pubmed: 28774193
Aust N Z J Psychiatry. 2002 Jun;36(3):340-6
pubmed: 12060182
Acta Psychiatr Scand. 2010 Sep;122(3):211-8
pubmed: 19922525
Schizophr Res. 2012 Dec;142(1-3):129-36
pubmed: 23084540
Behav Res Methods. 2016 Sep;48(3):936-49
pubmed: 26174714
Acta Psychiatr Scand. 1999 Aug;100(2):105-18
pubmed: 10480196
J Affect Disord. 2014 Feb;155:35-41
pubmed: 24210628
Neuropsychiatr Dis Treat. 2015 Mar 16;11:701-13
pubmed: 25834445
Psychol Assess. 2013 Mar;25(1):136-45
pubmed: 22800089
Am J Psychiatry. 2015 Feb 1;172(2):190-9
pubmed: 25322361
J Abnorm Psychol. 2017 May;126(4):454-477
pubmed: 28333488
Am J Psychiatry. 2016 Sep 1;173(9):876-86
pubmed: 27282362
Aust N Z J Psychiatry. 2012 Sep;46(9):826-39
pubmed: 22368242
Am J Psychiatry. 1988 Dec;145(12):1532-7
pubmed: 3057924
Am J Med Genet B Neuropsychiatr Genet. 2014 Jan;165B(1):84-95
pubmed: 24243780
BMC Psychiatry. 2010 Jul 29;10:60
pubmed: 20670449
Psychiatry Clin Neurosci. 2013 Sep;67(6):367-83
pubmed: 23890122
Psychol Med. 2001 Feb;31(2):189-95
pubmed: 11232907
Schizophr Res. 2018 Mar;193:100-106
pubmed: 28843437
Assessment. 2008 Jun;15(2):177-87
pubmed: 18182478
Arch Gen Psychiatry. 2012 Nov;69(11):1104-12
pubmed: 23117634
J Eval Clin Pract. 2009 Feb;15(1):134-41
pubmed: 19239593
Arch Gen Psychiatry. 2002 Apr;59(4):375-80
pubmed: 11926938
Schizophr Res. 2009 May;110(1-3):1-23
pubmed: 19328655
Br J Psychiatry. 1987 Aug;151:145-51
pubmed: 3690102
Eur Arch Psychiatry Clin Neurosci. 2005 Jun;255(3):202-12
pubmed: 15995904
J Pers Assess. 2010 Nov;92(6):544-59
pubmed: 20954056
Am J Psychiatry. 1993 Aug;150(8):1255-6
pubmed: 8328573
JAMA. 1990 Nov 21;264(19):2511-8
pubmed: 2232018
Schizophr Bull. 2002;28(2):223-31
pubmed: 12693429
Psychol Med. 2015 Aug;45(11):2375-87
pubmed: 25804221
Compr Psychiatry. 2012 Feb;53(2):145-51
pubmed: 21621754
Psychol Med. 2014 May;44(7):1391-401
pubmed: 23920138
Psychopathology. 1996;29(2):95-103
pubmed: 8861513
Br J Psychiatry. 2016 Aug;209(2):107-13
pubmed: 26989099
Schizophr Bull. 2002;28(4):683-95
pubmed: 12795498
Trends Genet. 2006 Jun;22(6):306-13
pubmed: 16697071
BMC Med. 2012 Dec 04;10:156
pubmed: 23210727
Int Clin Psychopharmacol. 2002 Aug;17 Suppl 3:S11-9
pubmed: 12570067
Biol Psychiatry. 2015 Dec 1;78(11):786-93
pubmed: 25863361
J Affect Disord. 2016 Feb;191:123-31
pubmed: 26655122
Am J Psychiatry. 1992 Jan;149(1):22-32
pubmed: 1728181
Behav Res Methods. 2011 Sep;43(3):701-9
pubmed: 21431996
Arch Gen Psychiatry. 1994 Jan;51(1):8-19
pubmed: 8279933
J Psychiatr Res. 2004 Jan;38(1):47-61
pubmed: 14690770
Aust N Z J Psychiatry. 2007 Oct;41(10):792-9
pubmed: 17828652
Psychol Med. 2013 Aug;43(8):1673-83
pubmed: 23171498
Lancet. 1995 Aug 19;346(8973):477-81
pubmed: 7637483
Psychiatry Res. 2004 Dec 15;129(2):141-7
pubmed: 15590041
Can J Psychiatry. 2003 Feb;48(1):14-21
pubmed: 12635559
Annu Rev Psychol. 2008;59:537-63
pubmed: 17937603
Psychol Assess. 2006 Mar;18(1):81-8
pubmed: 16594815
Am J Psychiatry. 2013 Nov;170(11):1263-74
pubmed: 23846857
World Psychiatry. 2007 Jun;6(2):84-91
pubmed: 18235858
Harv Rev Psychiatry. 1997 Jan-Feb;4(5):231-44
pubmed: 9385000
Perspect Psychol Sci. 2011 Jan;6(1):3-5
pubmed: 26162106
Behav Res Ther. 2003 Aug;41(8):923-47
pubmed: 12880647
Schizophr Res. 2017 May;183:49-55
pubmed: 27881233
J Clin Psychiatry. 2006;67 Suppl 7:5-9
pubmed: 16961418
Am J Psychiatry. 1985 Nov;142(11):1259-64
pubmed: 3904487
Psychol Med. 1975 May;5(2):181-92
pubmed: 1161956
Psychol Assess. 2009 Dec;21(4):498-505
pubmed: 19947784
Schizophr Res. 2011 Nov;132(2-3):177-82
pubmed: 21872443
Clin Psychol Rev. 2000 Mar;20(2):173-89
pubmed: 10721496
Neurotox Res. 2006 Dec;10(3-4):235-52
pubmed: 17197373
Psychol Med. 2001 Oct;31(7):1293-306
pubmed: 11681555
Schizophr Bull. 1999;25(1):157-71
pubmed: 10098919
Schizophr Bull. 2016 May;42(3):619-25
pubmed: 26536902

Auteurs

Emma E M Knowles (EEM)

Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. Electronic address: emma.knowles@yale.edu.

Samuel R Mathias (SR)

Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.

Godfrey D Pearlson (GD)

Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA; Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT, USA.

Jennifer Barrett (J)

Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT, USA.

Josephine Mollon (J)

Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.

Dominique Denbow (D)

Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT, USA.

Katrina Aberzik (K)

Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT, USA.

Molly Zatony (M)

Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT, USA.

David C Glahn (DC)

Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA; Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH